Knut Mikael Ingolf Lindstam
Algemeen Directeur bij Aptahem AB
Oorsprong van het eerstegraads netwerk van Knut Mikael Ingolf Lindstam
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
15
| Public Company | Pharmaceuticals: Major | 15 |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.
14
| Public Company | Pharmaceuticals: Major | 14 |
Accequa AB
1
| Private Company | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Knut Mikael Ingolf Lindstam via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| PROBI AB | Biotechnology | Chief Executive Officer | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer Chief Executive Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Imperial College London | College/University | Doctorate Degree | |
| University of Uppsala | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
| University of Stockholm | College/University | Doctorate Degree | |
| Université de Bordeaux | College/University | Graduate Degree | |
| University of Lund | College/University | Director/Board Member Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
| MENTICE AB | Medical Specialties | Director of Finance/CFO | |
| MAGFORCE AG | Medical Specialties | Founder | |
| University of Kalmar | College/University | Masters Business Admin | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
SP Sveriges Tekniska Forskningsinstitut AB
 SP Sveriges Tekniska Forskningsinstitut AB Miscellaneous Commercial ServicesCommercial Services SP Sveriges Tekniska Forskningsinstitut AB operates as a international research institute. Its business areas include energy, information and communications technology, life science, risk, safety and security, the built environment and transportation. The company was founded in 1920 and is headquartered in Borås, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer Chairman | |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| Rotterdam University | College/University | Graduate Degree | |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| LIDDS AB | Pharmaceuticals: Major | Chairman | |
| OxyPharma AB | Chief Executive Officer | ||
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Linnaeus | College/University | Undergraduate Degree | |
| MENDUS AB | Biotechnology | Chairman | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Founder Chairman | |
| Ideonfonden AB | Director/Board Member Chief Executive Officer | ||
| XINTELA AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
| GABATHER AB | Pharmaceuticals: Major | Founder Director/Board Member Director of Finance/CFO Director/Board Member | |
| Lund University School of Economics & Management | College/University | Masters Business Admin | |
| INVENT MEDIC SWEDEN AB | Medical Specialties | Director of Finance/CFO | |
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chairman Chief Executive Officer | |
| REDWOOD PHARMA AB | Pharmaceuticals: Major | Chairman | |
| LIPUM AB | Biotechnology | Chairman | |
| Ub-Consulting AB | Chief Executive Officer | ||
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Chairman | |
| Nordic Pharma Licensing Group | Director/Board Member | ||
| ANNEXIN PHARMACEUTICALS AB | Pharmaceuticals: Major | Director/Board Member | |
Ledningsresurs Syd AB
 Ledningsresurs Syd AB Miscellaneous Commercial ServicesCommercial Services Ledningsresurs Syd AB provides corporate consulting services. Ola Skanung has been the CEO of the Swedish company since 2010. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Flugsvampen Hhy AB | Chairman | ||
| Pig Sverige AB | Chairman | ||
| Classic Beauty Invest AB | Corporate Officer/Principal | ||
| Classic Beauty Göteborg AB | Corporate Officer/Principal | ||
| XO Sweden Wines & Spirits AB | Director/Board Member | ||
| FLUOGUIDE A/S | Pharmaceuticals: Major | Director of Finance/CFO | |
| ECTIN RESEARCH AB | Biotechnology | Chairman | |
| BIOME AUSTRALIA LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| Northern Lights Southern Cross AB | Chief Executive Officer | ||
| Immodulate Pharma AB | Chief Executive Officer | ||
| Bainan Biotech | Director/Board Member |
Statistieken
Internationaal
| Zweden | 39 |
| Denemarken | 5 |
| Noorwegen | 3 |
| Australië | 3 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 10 |
| Commercial Services | 6 |
Operationeel
| Director/Board Member | 85 |
| Chief Executive Officer | 33 |
| Chairman | 26 |
| Founder | 20 |
| Corporate Officer/Principal | 20 |
Sterkste connecties
| Insiders | |
|---|---|
| Theresa Comiskey Olsen | 27 |
| Bert Roland Kari Junno | 17 |
| Ulla Cristina Glad | 15 |
| Ulf Björklund | 14 |
| Kjell Göran Stenberg | 14 |
| Jan Nilsson | 12 |
| Michael Oredsson | 12 |
| Henrik Hang | 11 |
| Ingela Hallberg | 9 |
| Tara Renée Heitner Hansen | 9 |
| Åsa Kornfeld | 7 |
| Ola Skanung | 7 |
| Carl Magnus Högerkorp | 7 |
| Anders Bylock | 6 |
| Peter Heinrich | 6 |
- Beurs
- Insiders
- Knut Mikael Ingolf Lindstam
- Bedrijfsconnecties
